Search results for "Cutaneous"

showing 10 items of 1022 documents

Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound

2007

Radiofrequency ablation (RFA) is increasingly being used as percutaneous treatment of choice for patients with early stage hepatocellular carcinoma (HCC). An accurate assessment of the RFA therapeutic response is of crucial importance, considering that a complete tumor ablation significantly increases patient survival, whereas residual unablated tumor calls for additional treatment. Imaging modalities play a pivotal role in accomplishing this task, but ultrasound (US) is not considered a reliable modality for the evaluation of the real extent of necrosis, even when color/power Doppler techniques are used. Recently, newer microbubble-based US contrast agents used in combination with grey-sca…

Malemedicine.medical_specialtyCarcinoma HepatocellularPercutaneousRadiofrequency ablationUrologymedicine.medical_treatmentSulfur HexafluorideContrast MediaCatheter ablationSensitivity and Specificitylaw.inventionImaging Three-DimensionallawHumansMedicineRadiology Nuclear Medicine and imagingStage (cooking)PhospholipidsUltrasonography InterventionalAgedAged 80 and overRadiological and Ultrasound Technologybusiness.industryLiver NeoplasmsUltrasoundGastroenterologyGeneral MedicineRadiofrequency ablationcontrast-enhanced ultrasound hepatocellular carcinomamedicine.diseaseTreatment OutcomeHepatocellular carcinomaCatheter AblationDisease ProgressionMicrobubblesFemaleRadiologybusinessContrast-enhanced ultrasoundAbdominal Imaging
researchProduct

Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Before Liver Transplantation: A Prospective Study with Histopathologic Comparison

2006

OBJECTIVE. The aims of this study were to determine the feasibility and efficacy of percutaneous radiofrequency ablation in patients with hepatocellular carcinoma waiting for liver transplantation and to compare the radiologic and pathologic findings. SUBJECTS AND METHODS. Twenty-six patients with 35 hepatocellular carcinomas were addressed for transplantation. Complications of the procedures were recorded. Primary and secondary technique effectiveness and causes of exclusion from the waiting list were assessed. After transplantation, tumor recurrence was evaluated for at least 1 year in all patients. Radiologic-pathologic comparison of the explant was performed. RESULTS. Percutaneous radio…

Malemedicine.medical_specialtyCarcinoma HepatocellularPercutaneousRadiofrequency ablationmedicine.medical_treatmentLiver transplantationlaw.inventionlawPreoperative CaremedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyablation cancer hepatocellular carcinoma liver transplantation radiofrequencybusiness.industryLiver NeoplasmsCancerGeneral MedicineMiddle Agedmedicine.diseaseAblationLiver TransplantationSurgeryRadiographyTransplantationHepatocellular carcinomaCatheter AblationFeasibility StudiesFemaleRadiologybusinessFollow-Up StudiesAmerican Journal of Roentgenology
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation

2009

Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long-term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure. Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV-AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsThromboembolism.left atrial appendage occlusionmedicine.medical_treatmentEmbolismSettore MED/11 - Malattie dell'Apparato CardiovascolareTransesophagealLeft atrial appendage occlusionPericardial effusionRisk AssessmentLeft atrialInternal medicineAtrial FibrillationmedicineHumansRadiology Nuclear Medicine and imagingAtrial Appendageatrial fibrillation; left atrial appendage occlusion; thromboembolism; Aged; Atrial Fibrillation; Contraindications; Echocardiography Transesophageal; Embolism; Equipment Design; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Anticoagulants; Atrial Appendage; Cardiac Catheterization; Chronic DiseaseStrokeAgedbusiness.industryContraindicationsAnticoagulantsAtrial fibrillationGeneral MedicineEquipment DesignthromboembolismMiddle Agedmedicine.diseaseSurgeryStrokeTreatment OutcomePericardiocentesisEchocardiographyChronic DiseaseCardiologyPatent foramen ovaleFeasibility StudiesFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealPlatelet Aggregation Inhibitors
researchProduct

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological …

2013

Background: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. Aim: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. Methods: A cohort of 151 consecutive patients with early stage HCC (122 Child-Pugh class A and 29 class B patients) treated with RFA were enrolled. Clinical, laboratory and radiological follow-up data were collected from the time of first RFA. A single lesion was observed in 113/151 (74.8%), two lesions in 32/151 (21.2%), and three lesions in 6/151 (4%) of patients. Results: The overall survival rates …

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma HepatocellularClinical Research Designmedicine.medical_treatmentCancer Treatmentlcsh:MedicineCatheter ablationGastroenterology and HepatologyGastroenterologyCohort StudiesInternal medicineGastrointestinal CancersGastrointestinal TumorsmedicineHumansStage (cooking)lcsh:ScienceAgedMultidisciplinaryRadiotherapybusiness.industryLiver Diseaseslcsh:RLiver NeoplasmsCancers and NeoplasmsHepatocellular CarcinomaMiddle Agedmedicine.diseaseAblationFibrosisdigestive system diseasessurgical procedures operativeTreatment OutcomeCirrhosisOncologyRadiological weaponHepatocellular carcinomaCatheter AblationMedicineHepatocellular carcinoma survival RFAlcsh:QFemalebusinessLiver cancerResearch ArticlePloS one
researchProduct

Eurotransplant special request for high-urgency status after liver transplantation for hepatocellular carcinoma: a case report.

2008

Hepatic artery thrombosis after liver transplantation remains a major indication for retransplantation. We report the case of a 49-year-old man with a hepatocellular carcinoma in the setting of cirrhosis associated with chronic hepatitis B and C infections who underwent split liver transplantation. The patient experienced a complicated postoperative course, characterized by 2 relaparotomies for necrosis of segment IV, and a late hepatic artery thrombosis, first discovered on postoperative day 20. His subsequent course was characterized by relapsing cholangitis and liver abscesses requiring antibiotics and percutaneous drainage. Transient control of the septic complications allowed for the f…

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationNecrosisHepatic ArterymedicineHumansTransplantationDeceased donorbusiness.industryLiver NeoplasmsCancerThrombosisMiddle Agedmedicine.diseaseHepatitis BHepatitis CSurgeryTumor recurrenceLiver TransplantationTreatment OutcomeHepatocellular carcinomaSurgeryEmergenciesLiver cancerbusinessTransplantation proceedings
researchProduct

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

2021

Over the past 2 decades, chronic total occlusion (CTO) percutaneous coronary intervention has developed into its own subspecialty of interventional cardiology. Dedicated terminology, techniques, devices, courses, and training programs have enabled progressive advancements. However, only a few randomized trials have been performed to evaluate the safety and efficacy of CTO percutaneous coronary intervention. Moreover, several published observational studies have shown conflicting data. Part of the paucity of clinical data stems from the fact that prior studies have been suboptimally designed and performed. The absence of standardized end points and the discrepancy in definitions also prevent…

Malemedicine.medical_specialtyClinical trial protocols as topicmedicine.medical_treatmentPsychological intervention030204 cardiovascular system & hematologySubspecialtylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysiology (medical)MedicineHumansMedical physics030212 general & internal medicineCoronary VesselClinical Trials as TopicInterventional cardiologybusiness.industryClinical study designPercutaneous coronary interventionCoronary VesselsCoronary OcclusionCoronary occlusionEndpoint determination:Myocardial revascularizationObservational studyFemaleCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy

2005

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy. Cordova A, Corradino B, Pirrello R, Di Lorenzo S, Dispenza C, Moschella F. Source Dipratimento di Discipline Chirurgiche ed Oncologiche, Divisione di Chirurgia Plastica e Ricostruttiva, Facolta di Medicina, Universita di Palermo, Palermo, Italy. chirplas@unipa.it Abstract CONCLUSION: Our experience confirms that pectoralis major flap is the first-choice technique for repairing recurrent hypopharyngeal fistulae in previously irradiated patients in whom microsurgical techniques are not indicated, and that hyperbaric oxygen therapy helps to solv…

Malemedicine.medical_specialtyCutaneous FistulaFistulamedicine.medical_treatmentLaryngectomyHyperbaric oxygen therapy hypopharyngeal fistula pectoralis major flap pharyngolaryngeal carcinoma pharyngolaryngeal reconstruction pharyngostomeSurgical FlapsPectoralis MusclesPostoperative ComplicationsCarcinomamedicineHumansSurgical FlapsPectoralis MuscleLaryngeal NeoplasmsAgedAged 80 and overHyperbaric Oxygenationbusiness.industryPectoralis major musclePharyngeal NeoplasmsPharyngeal DiseasesGeneral MedicineMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurgeryLaryngectomyTreatment OutcomePharyngeal NeoplasmOtorhinolaryngologyFemaleRadiotherapy AdjuvantComplicationbusiness
researchProduct

Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry).

2002

There is conflicting information about gender differences in presentation, treatment, and outcome after acute ST elevation myocardial infarction (STEMI) in the era of thrombolytic therapy and primary percutaneous coronary intervention. From June 1994 to January 1997, we enrolled 6,067 consecutive patients with STEMI admitted to 54 hospitals in southwest Germany in the Maximal Individual TheRapy of Acute myocardial infarction (MITRA), a community-based registry. Women were 9 years older than men, more often had hypertension, diabetes mellitus, and congestive heart failure, and had a history of previous myocardial infarction less often. Women had a longer prehospital delay (45 minutes), had a…

Malemedicine.medical_specialtyEmergency Medical Servicesmedicine.medical_treatmentMyocardial InfarctionInfarctionAngina PectorisAnginaReperfusion therapySex FactorsInternal medicineGermanymedicineHumansThrombolytic TherapyMyocardial infarctionHospital MortalityProspective StudiesRegistriesAgedHeart Failurebusiness.industryPercutaneous coronary interventionThrombolysisOdds ratioMiddle Agedmedicine.diseaseSurvival AnalysisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessThe American journal of cardiology
researchProduct

Psychological insulin resistance in geriatric patients with diabetes mellitus.

2013

To determine the extent to which geriatric patients with diabetes mellitus experience psychological insulin resistance (PIR).A total of 67 unselected geriatric patients with diabetes (mean age 82.8±6.7 years, diabetes duration 12.2 [0.04-47.2] years, 70.1% female) were recruited in a geriatric care center of a university hospital. A comprehensive geriatric assessment (CGA) was performed including WHO-5, Hospital Anxiety and Depression Scale (HADS), Mini Mental State Examination (MMSE) and Barthel-Index. We assessed PIR using the Barriers of Insulin Treatment Questionnaire (BIT) and the Insulin Treatment Appraisal Scale in a face-to-face interview.Insulin-naïve patients (INP) showed higher P…

Malemedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentInjections SubcutaneousHospital Anxiety and Depression ScaleInsulin resistanceQuality of lifeInternal medicineDiabetes mellitusSurveys and QuestionnairesmedicineHumansHypoglycemic AgentsInsulinPsychiatryGeriatric AssessmentDepression (differential diagnoses)AgedAged 80 and overPsychiatric Status Rating ScalesDepressive DisorderMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryDepressionInsulinGeneral MedicineFearPatient Acceptance of Health CareUniversity hospitalmedicine.diseaseDiabetes Mellitus Type 2Quality of LifeFemaleInsulin ResistancebusinessPatient education and counseling
researchProduct